You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Haemophagocytic Lymphohistiocytosis

Showing 1 - 25 of 96
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Haemophagocytic Lymphohistiocytosis Trial (Ruxolitinib)

Not yet recruiting
  • Haemophagocytic Lymphohistiocytosis
  • (no location specified)
Feb 28, 2023

Assessing the Presence of CT-DNA in Lymphoma Associated HLH

Not yet recruiting
  • Lymphoma
  • Haemophagocytic Lymphohistiocytosis
    • (no location specified)
    Jan 25, 2023

    Primary Haemophagocytic Lymphohistiocytosis Trial in Worldwide (NI-0501)

    Completed
    Has Results
    • Primary Haemophagocytic Lymphohistiocytosis
    • NI-0501
    • Aurora, Colorado
    • +19 more
    Apr 23, 2021

    Primary Hemophagocytic Lymphohistiocytosis Trial in Worldwide (Emapalumab)

    Active, not recruiting
    • Primary Hemophagocytic Lymphohistiocytosis
    • Phoenix, Arizona
    • +27 more
    Nov 4, 2021

    Hemophagocytic Lymphohistiocytoses, Cytokine Storm Trial in Hangzhou (Dexamethasone, Etoposide, Ruxolitinib)

    Not yet recruiting
    • Hemophagocytic Lymphohistiocytoses
    • Cytokine Storm
    • Hangzhou, Zhejiang, China
      The Children's Hospital of Zhejiang University School of Medicin
    Aug 4, 2022

    Immunodeficiency for Severe Epstein-Barr Virus Infection

    Recruiting
    • Epstein-Barr Virus Infections
    • Immunodeficiency
      • Shanghai, Shanghai, China
        Children's Hospital of Fudan University
      Mar 21, 2022

      Hemophagocytic Lymphohistiocytosis Trial in Philadelphia (tocilizumab)

      Withdrawn
      • Hemophagocytic Lymphohistiocytosis
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Mar 11, 2022

      EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD) Trial in Switzerland (Donor-derived ex-vivo expanded EBV Tscm

      Not yet recruiting
      • EBV Lymphoma
      • Post-transplant Lymphoproliferative Disease (PTLD)
      • Donor-derived ex-vivo expanded EBV Tscm CTL
      • Basel, Switzerland
      • +7 more
      Jan 25, 2023

      Covid19, Corticosteroids Trial in Maadi (Early-Corticosteroids)

      Completed
      • Covid19
      • Corticosteroids
      • Maadi, Cairo, Egypt
        Asalam
      Jan 15, 2022

      COVID-19 Trial in Belgium (Usual Care, Anakinra, Siltuximab)

      Completed
      • COVID-19
      • Usual Care
      • +3 more
      • Brugge, Belgium
      • +14 more
      Sep 28, 2021

      Novel Factors Leading to Activated Macrophage Expansion in

      Active, not recruiting
      • Covid19
      • SARS-CoV-2 Infection
      • Soton hyperinflammation score
      • HScore
      • Southampton, Hampshire, United Kingdom
        University Hospitals Southampton NHS Foundation Trust
      May 25, 2021

      B-cell Acute Lymphoblastic Leukemia Trial in Worldwide (CTL019)

      Active, not recruiting
      Has Results
      • B-cell Acute Lymphoblastic Leukemia
      • CTL019
      • Los Angeles, California
      • +24 more
      Jun 23, 2022

      Lymphoma-associated Hemophagocytic Lymphohistiocytosis

      Recruiting
      • Lymphoma
      • Hemophagocytic Lymphohistiocytoses
        • Birmingham, Alabama
          University of Alabama at Birmingham
        Jun 1, 2023

        COVID-19 Acute Respiratory Distress Syndrome, Cytokine Release Syndrome, Pulmonary Fibrosis Trial (cyclosporine)

        Not yet recruiting
        • COVID-19 Acute Respiratory Distress Syndrome
        • +2 more
        • (no location specified)
        Jul 26, 2021

        Carbapenem Resistant Bacterial Infection, Hemophagocytic Lymphohistiocytoses Trial in Beijing (Carrimycin tablets)

        Not yet recruiting
        • Carbapenem Resistant Bacterial Infection
        • Hemophagocytic Lymphohistiocytoses
        • Carrimycin tablets
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Aug 4, 2023

        EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

        Recruiting
        • EBV-associated Hemophagocytic Lymphohistiocytosis
        • EBV Infection
        • EBV-TCR-T cells
        • Beijing, Beijing, China
          Chinese PLA General Hospital
        Nov 12, 2023

        Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Trial in Worldwide (ELA026)

        Recruiting
        • Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
        • Innsbruck, Austria
        • +9 more
        Oct 24, 2022

        COVID-19 Trial in Belgium (Sargramostim, Control)

        Completed
        • COVID-19
        • Brugge, Belgium
        • +3 more
        Mar 1, 2021

        PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)

        Not yet recruiting
        • PD-1 Antibody
        • +3 more
        • L-DEP and PD-1 antibody
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Mar 8, 2023

        Adults Patients Having Non Severe HLH Trial in Bobigny (Itacitinib)

        Recruiting
        • Adults Patients Having Non Severe HLH
        • Bobigny, France
          Hôpital Avicenne
        Aug 22, 2022

        Refractory, Recurrence, Hemophagocytic Lymphohistiocytosis Trial (GTP regimen)

        Not yet recruiting
        • Refractory
        • +2 more
        • GTP regimen
        • (no location specified)
        Sep 8, 2023

        Advanced Solid Malignancies Trial in Worldwide (MEDI4736 (Durvalumab), MEDI4736 (Durvalumab) + Tremelimumab)

        Active, not recruiting
        Has Results
        • Advanced Solid Malignancies
        • MEDI4736 (Durvalumab)
        • MEDI4736 (Durvalumab) + Tremelimumab
        • Santa Rosa, California
        • +78 more
        Aug 18, 2022

        Hemophagocytic Lymphohistiocytosis Trial in Beijing (Venetoclax, Dexamethasone, Etoposide)

        Recruiting
        • Hemophagocytic Lymphohistiocytosis
        • Beijing, Beijing, China
          Beijing Friendship Hospital, Capital Medical University
        Sep 15, 2022

        Hemophagocytic Lymphohistiocytoses Trial in Cincinnati

        Recruiting
        • Hemophagocytic Lymphohistiocytoses
          • Cincinnati, Ohio
            Cincinnati Children's Hospital Medical Center
          Oct 25, 2022

          NSCLC (NSCLC), Non-Small-Cell Lung Carcinoma, Nonsmall Cell Lung Cancer Trial in India (Nivolumab)

          Completed
          Has Results
          • Non-Small Cell Lung Cancer (NSCLC)
          • +6 more
          • Bangalore, India
          • +8 more
          Dec 3, 2020